Company / Operating Income per Share
Protalix BioTherapeutics, Inc. Operating Income per Share History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$0.14
FY2025
5-year range
-$0.38 / $0.14
FY2021-FY2025
Trend
+177.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has fluctuated over the past 10 years, ranging from $-2.33 in FY2019 to $0.14 in FY2025.
Based on SEC 10-K filings.
0.14 in FY2025 with a 3-year CAGR of +32.3%.
Improved from $-0.38 to $0.14 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- +32.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 177.3% year-over-year.
- Lowest operating income per share in the period was in FY2019.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.14 | +177.3% |
| FY2024 | -$0.18 | +53.1% |
| FY2023 | -$0.38 | -739.5% |
| FY2022 | $0.06 | +119.3% |
| FY2021 | -$0.31 | +76.3% |
| FY2020 | -$1.30 | +44.1% |
| FY2019 | -$2.33 | -1120.0% |
| FY2017 | -$0.19 | +33.4% |
| FY2016 | -$0.29 | +21.4% |
| FY2015 | -$0.36 | -179.7% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026